| 109.40 Delayed Data As of Nov 20 |  -0.70 / -0.64%Today’s Change | 92.38 Today|||52-Week Range 112.60 | +0.91% Year-to-Date |
| Previous close | 110.10 |
| Today’s open | 109.25 |
| Day’s range | 109.25 - 109.40 |
| Volume | 38 |
| Average volume (3 months) | 2,279 |
| Market cap | $14.1B |
| Earnings growth (last year) | +62.60% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +4.02% |
| P/E ratio | 17.4 |
| Price/Sales | 2.71 |
| Price/Book | 2.83 |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $17.3B |
| Annual profit (last year) | $2.9B |
| Net profit margin | 16.96% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman-Executive Board & CEO Stefan Oschmann |
Chief Financial Officer Marcus Kuhnert |
Corporate headquarters Darmstadt, Hessen |
